Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2000 Jun;76(3):162–168. doi: 10.1136/sti.76.3.162

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts

G von Krogh 1, C Lacey 1, G Gross 1, R Barrasso 1, A Schneider 1
PMCID: PMC1744154  PMID: 10961190

Abstract

The European Course on HPV Associated Pathology (ECHPV) was founded in 1990 by a group of clinicians, pathologists, and virologists to teach important principles for the practice and management of human papillomavirus (HPV) disease to gynaecologists, dermatologists, and other medical disciplines. These guidelines are intended to assist the practice of primary care physicians for diagnosis and treatment of anogenital warts.

Key Words: anogenital warts; human papillomavirus; condylomata acuminata; guidelines

Full Text

The Full Text of this article is available as a PDF (151.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdullah A. N., Walzman M., Wade A. Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloroacetic acid. Sex Transm Dis. 1993 Nov-Dec;20(6):344–345. [PubMed] [Google Scholar]
  2. Alloub M. I., Barr B. B., McLaren K. M., Smith I. W., Bunney M. H., Smart G. E. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ. 1989 Jan 21;298(6667):153–156. doi: 10.1136/bmj.298.6667.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beutner K. R., Conant M. A., Friedman-Kien A. E., Illeman M., Artman N. N., Thisted R. A., King D. H. Patient-applied podofilox for treatment of genital warts. Lancet. 1989 Apr 15;1(8642):831–834. doi: 10.1016/s0140-6736(89)92282-4. [DOI] [PubMed] [Google Scholar]
  4. Chuang T. Y., Perry H. O., Kurland L. T., Ilstrup D. M. Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol. 1984 Apr;120(4):469–475. [PubMed] [Google Scholar]
  5. Claesson U., Lassus A., Happonen H., Hogström L., Siboulet A. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS. 1996 Oct;7(6):429–434. doi: 10.1258/0956462961918400. [DOI] [PubMed] [Google Scholar]
  6. Cook L. S., Koutsky L. A., Holmes K. K. Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic. Genitourin Med. 1993 Aug;69(4):262–264. doi: 10.1136/sti.69.4.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Demeter L. M., Stoler M. H., Bonnez W., Corey L., Pappas P., Strussenberg J., Reichman R. C. Penile intraepithelial neoplasia: clinical presentation and an analysis of the physical state of human papillomavirus DNA. J Infect Dis. 1993 Jul;168(1):38–46. doi: 10.1093/infdis/168.1.38. [DOI] [PubMed] [Google Scholar]
  8. Drake L. A., Ceilley R. I., Cornelison R. L., Dobes W. L., Dorner W., Goltz R. W., Lewis C. W., Salasche S. J., Chanco Turner M. L., Lowery B. J. Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol. 1995 Jan;32(1):98–103. doi: 10.1016/0190-9622(95)90192-2. [DOI] [PubMed] [Google Scholar]
  9. Edwards L., Ferenczy A., Eron L., Baker D., Owens M. L., Fox T. L., Hougham A. J., Schmitt K. A. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol. 1998 Jan;134(1):25–30. doi: 10.1001/archderm.134.1.25. [DOI] [PubMed] [Google Scholar]
  10. Euvrard S., Kanitakis J., Chardonnet Y., Noble C. P., Touraine J. L., Faure M., Thivolet J., Claudy A. External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol. 1997 Feb;133(2):175–178. [PubMed] [Google Scholar]
  11. Feldman J. G., Chirgwin K., Dehovitz J. A., Minkoff H. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol. 1997 Mar;89(3):346–350. doi: 10.1016/S0029-7844(97)00011-2. [DOI] [PubMed] [Google Scholar]
  12. Fisher A. A. Severe systemic and local reactions to topical podophyllum resin. Cutis. 1981 Sep;28(3):233–passim. [PubMed] [Google Scholar]
  13. Godley M. J., Bradbeer C. S., Gellan M., Thin R. N. Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med. 1987 Dec;63(6):390–392. doi: 10.1136/sti.63.6.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Greenberg M. D., Rutledge L. H., Reid R., Berman N. R., Precop S. L., Elswick R. K., Jr A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol. 1991 May;77(5):735–739. [PubMed] [Google Scholar]
  15. Gross G., Hagedorn M., Ikenberg H., Rufli T., Dahlet C., Grosshans E., Gissmann L. Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol. 1985 Jul;121(7):858–863. doi: 10.1001/archderm.121.7.858. [DOI] [PubMed] [Google Scholar]
  16. Gross G., Ikenberg H., Gissmann L., Hagedorn M. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol. 1985 Aug;85(2):147–152. doi: 10.1111/1523-1747.ep12276576. [DOI] [PubMed] [Google Scholar]
  17. Gross G., Rogozinski T., Schöfer H., Jabłońska S., Roussaki A., Wöhr C., Brzoska J. Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double-blind study in 120 patients. Dermatology. 1998;196(3):330–334. doi: 10.1159/000017906. [DOI] [PubMed] [Google Scholar]
  18. Gross G., Roussaki A., Baur S., Wiegand M., Mescheder A. Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial. Genitourin Med. 1996 Feb;72(1):71–71. doi: 10.1136/sti.72.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hording U., Daugaard S., Junge J., Lundvall F. Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol. 1996 Jul;15(3):230–234. doi: 10.1097/00004347-199607000-00007. [DOI] [PubMed] [Google Scholar]
  20. Ingram D. L., Everett V. D., Lyna P. R., White S. T., Rockwell L. A. Epidemiology of adult sexually transmitted disease agents in children being evaluated for sexual abuse. Pediatr Infect Dis J. 1992 Nov;11(11):945–950. doi: 10.1097/00006454-199211110-00008. [DOI] [PubMed] [Google Scholar]
  21. Jensen S. L. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata. Lancet. 1985 Nov 23;2(8465):1146–1148. doi: 10.1016/s0140-6736(85)92677-7. [DOI] [PubMed] [Google Scholar]
  22. Kashima H. K., Shah K. Recurrent respiratory papillomatosis. Clinical overview and management principles. Obstet Gynecol Clin North Am. 1987 Jun;14(2):581–588. [PubMed] [Google Scholar]
  23. Kemp E. A., Hakenewerth A. M., Laurent S. L., Gravitt P. E., Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol. 1992 May;79(5 ):649–656. [PubMed] [Google Scholar]
  24. Kirby P., Dunne A., King D. H., Corey L. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med. 1990 May;88(5):465–469. doi: 10.1016/0002-9343(90)90424-c. [DOI] [PubMed] [Google Scholar]
  25. Leslie K. O., Shitamoto B. The bone marrow in systemic podophyllin toxicity. Am J Clin Pathol. 1982 Apr;77(4):478–480. doi: 10.1093/ajcp/77.4.478. [DOI] [PubMed] [Google Scholar]
  26. Maw R. D., Reitano M., Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS. 1998 Oct;9(10):571–578. doi: 10.1258/0956462981921143. [DOI] [PubMed] [Google Scholar]
  27. Miller R. A. Podophyllin. Int J Dermatol. 1985 Oct;24(8):491–498. doi: 10.1111/j.1365-4362.1985.tb05827.x. [DOI] [PubMed] [Google Scholar]
  28. Miller R. L., Gerster J. F., Owens M. L., Slade H. B., Tomai M. A. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol. 1999 Jan;21(1):1–14. doi: 10.1016/s0192-0561(98)00068-x. [DOI] [PubMed] [Google Scholar]
  29. Oriel J. D. Natural history of genital warts. Br J Vener Dis. 1971 Feb;47(1):1–13. doi: 10.1136/sti.47.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Petersen C. S., Agner T., Ottevanger V., Larsen J., Ravnborg L. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts. Genitourin Med. 1995 Dec;71(6):391–392. doi: 10.1136/sti.71.6.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Petersen C. S., Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourin Med. 1995 Apr;71(2):92–93. doi: 10.1136/sti.71.2.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Simmons P. D., Langlet F., Thin R. N. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis. 1981 Aug;57(4):273–274. doi: 10.1136/sti.57.4.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sonnex C., Scholefield J. H., Kocjan G., Kelly G., Whatrup C., Mindel A., Northover J. M. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. BMJ. 1991 Nov 16;303(6812):1243–1243. doi: 10.1136/bmj.303.6812.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stone K. M., Becker T. M., Hadgu A., Kraus S. J. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med. 1990 Feb;66(1):16–19. doi: 10.1136/sti.66.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Strand A., Brinkeborn R. M., Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med. 1995 Dec;71(6):387–390. doi: 10.1136/sti.71.6.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Syrjänen K. Long-term consequences of genital HPV infections in women. Ann Med. 1992 Aug;24(4):233–235. doi: 10.3109/07853899209149950. [DOI] [PubMed] [Google Scholar]
  37. Syrjänen K., Syrjänen S. Epidemiology of human papilloma virus infections and genital neoplasia. Scand J Infect Dis Suppl. 1990;69:7–17. [PubMed] [Google Scholar]
  38. Taylor C. A., Keller M. L., Egan J. J. Advice from affected persons about living with human papillomavirus infection. Image J Nurs Sch. 1997 Spring;29(1):27–32. doi: 10.1111/j.1547-5069.1997.tb01136.x. [DOI] [PubMed] [Google Scholar]
  39. Tomczak R. L., Hake D. H. Near fatal systemic toxicity from local injection of podophyllin for pedal verrucae treatment. J Foot Surg. 1992 Jan-Feb;31(1):36–42. [PubMed] [Google Scholar]
  40. Tyring S. K., Arany I., Stanley M. A., Tomai M. A., Miller R. L., Smith M. H., McDermott D. J., Slade H. B. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis. 1998 Aug;178(2):551–555. doi: 10.1086/517472. [DOI] [PubMed] [Google Scholar]
  41. Wein A. J., Benson G. S. Treatment of urethral condyloma acuminatum with 5-fluorouracil cream. Urology. 1977 Apr;9(4):413–415. doi: 10.1016/0090-4295(77)90218-7. [DOI] [PubMed] [Google Scholar]
  42. Wikström A., Hedblad M. A., Johansson B., Kalantari M., Syrjänen S., Lindberg M., von Krogh G. The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med. 1992 Apr;68(2):90–99. doi: 10.1136/sti.68.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van Beurden M., ten Kate F. J., Smits H. L., Berkhout R. J., de Craen A. J., van der Vange N., Lammes F. B., ter Schegget J. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer. 1995 Jun 15;75(12):2879–2884. doi: 10.1002/1097-0142(19950615)75:12<2879::aid-cncr2820751214>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  44. von Krogh G. Penile condylomata acuminata: an experimental model for evaluation of topical self-treatment with 0.5--1.0% ethanolic preparations of podophyllotoxin for three days. Sex Transm Dis. 1981 Jul-Sep;8(3):179–186. [PubMed] [Google Scholar]
  45. von Krogh G. Podophyllotoxin for condylomata acuminata eradication. Clinical and experimental comparative studies on Podophyllum lignans, colchicine and 5-fluorouracil. Acta Derm Venereol Suppl (Stockh) 1981;98:1–48. [PubMed] [Google Scholar]
  46. von Krogh G. Podophyllotoxin in serum: absorption subsequent to three-day repeated applications of a 0.5% ethanolic preparation on condylomata acuminata. Sex Transm Dis. 1982 Jan-Mar;9(1):26–33. [PubMed] [Google Scholar]
  47. von Krogh G., Szpak E., Andersson M., Bergelin I. Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study. Genitourin Med. 1994 Apr;70(2):105–109. doi: 10.1136/sti.70.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. von Krogh G., Wikström A. Efficacy of chemical and/or surgical therapy against condylomata acuminata: a retrospective evaluation. Int J STD AIDS. 1991 Sep-Oct;2(5):333–338. doi: 10.1177/095646249100200504. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES